TI
RCUS icon

Trexquant Investment’s Arcus Biosciences RCUS Stock Holding History

Trexquant Investment’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-47,593
Closed -$647K – 1872
2025
Q3 		$647K Sell
47,593
-211,344
-82% -$2.2M 0.01% 1261
2025
Q2 		$2.11M Buy
258,937
+43,571
+20% +$372K 0.02% 872
2025
Q1 		$1.69M Sell
215,366
-85,182
-28% -$988K 0.02% 919
2024
Q4 		$4.48M Buy
300,548
+212,552
+242% +$3.47M 0.05% 562
2024
Q3 		$1.35M Sell
87,996
-164,590
-65% -$2.6M 0.02% 945
2024
Q2 		$3.85M Buy
252,586
+214,469
+563% +$3.46M 0.06% 489
2024
Q1 		$720K Sell
38,117
-5,420
-12% -$93.7K 0.01% 1039
2023
Q4 		$832K Sell
43,537
-35,100
-45% -$561K 0.02% 889
2023
Q3 		$1.41M Buy
+78,637
New +$1.58M 0.04% 617
2023
Q2 		– Sell
-18,827
Closed -$343K – 1740
2023
Q1 		$343K Sell
18,827
-6,244
-25% -$119K 0.01% 1145
2022
Q4 		$518K Buy
+25,071
New +$690K 0.01% 902
2022
Q3 		– Sell
-8,190
Closed -$208K – 1767
2022
Q2 		$208K Buy
+8,190
New +$201K 0.01% 1334
2021
Q2 		– Sell
-7,189
Closed -$202K – 1436
2021
Q1 		$202K Sell
7,189
-6,236
-46% -$217K 0.02% 963
2020
Q4 		$349K Sell
13,425
-39,251
-75% -$950K 0.04% 606
2020
Q3 		$903K Buy
52,676
+23,327
+79% +$521K 0.06% 454
2020
Q2 		$726K Buy
29,349
+3,040
+12% +$82K 0.05% 524
2020
Q1 		$365K Buy
+26,309
New +$327K 0.03% 778
2019
Q2 		– Sell
-16,361
Closed -$204K – 1066
2019
Q1 		$204K Buy
+16,361
New +$178K 0.01% 864

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Trexquant Investment's RCUS Position: Q4 2025 in Review

Trexquant Investment sold out of Arcus Biosciences (RCUS) in Q4 2025, closing a stake of 47,593 shares — an estimated $647K sold.

Trexquant Investment first reported a position in RCUS in Q1 2019 and held it in 18 quarters. The position peaked at $4.48M in Q4 2024. 209 funds tracked by Wall St. Rank hold RCUS as of Q4 2025.

  • Trexquant Investment reported no remaining Arcus Biosciences position as of Q4 2025 after selling out during the quarter.
  • Trexquant Investment sold 47,593 Arcus Biosciences shares in Q4 2025, an estimated $647K.
  • Trexquant Investment first reported a position in Arcus Biosciences in Q1 2019 and held it in 18 quarters.
  • Trexquant Investment's Arcus Biosciences position peaked at $4.48M in Q4 2024.
  • 209 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2025.

Based on Trexquant Investment's 13F filing for Q4 2025, filed 17 Feb 2026.